RJ-34 is an aristolactam analogue with antitumor activities against a panel of cancer cell lines with GI50 values in the subnanomolar range (GI50<0.1 nM for A431, MES-SA, MES-SA/DX5, HCT-15, and HCT-15/CLO2 cells).

纯度：≥98%

CAS：1170694-29-7